Christine Simmon, Executive Director of AAM’s Biosimilars Council, reacts to the recent release of FDA’s Biosimilars Action Plan
Christine Simmon, Executive Director of AAM’s Biosimilars Council, reacts to the recent release of FDA’s Biosimilars Action Plan
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.
For the latest updates, follow us on social media.
